Eyantra's revenue tripled after hospital deal, but full-year profit vanished
Consolidated top line hit ₹94.2 crore on the back of Neuro and Spine Associates, but the healthcare push cost the group ₹4.75 crore for the full year.
— 1 earlier story on Eyantra ventures Ltd. →What's new
- Consolidated revenue surged to ₹94.2 crore as Neuro and Spine Associates added ₹20.5 crore in hospital revenue.
- Full-year consolidated net loss of ₹4.75 crore, swung by the new healthcare subsidiary.
- Q4 standalone profit rebounded to ₹6.8 crore; auditor gave an unmodified opinion.
Why this matters
The acquisition of a 60% stake in Neuro and Spine Associates has reshaped Eyantra's financials. The new healthcare segment is driving top-line growth but also absorbing profits, turning a formerly profitable standalone entity into a loss-making consolidated group for the year. Q4's swing back to profit is the first sign that the new business might be stabilising.
What we're watching
- Whether Q4's ₹6.8 crore profit carries into FY27.
- The standalone profit decline from ₹1.66 cr to ₹26.5 lakh.
- Hospital revenue run-rate post the ₹10.4 crore Q4 surge.
The full read
Eyantra Ventures is now a different company. The acquisition of a 60% stake in Neuro and Spine Associates drove consolidated revenue to ₹94.2 crore, nearly triple the prior year's ₹31 crore. The new hospital services segment alone contributed ₹20.5 crore. But the healthcare push came at a cost: the consolidated group posted a full-year net loss of ₹4.75 crore, a stark reversal from the previously profitable standalone business. Standalone profit fell to ₹26.5 lakh from ₹1.66 crore. There is a silver lining. In the March quarter, consolidated profit swung to ₹6.8 crore on hospital revenue that surged to ₹10.4 crore from ₹3.4 crore in the prior quarter. That's the first full quarter where the new healthcare subsidiary appears to be contributing positively. The auditor's unmodified opinion gives the numbers credibility. The question now is whether Q4's profitability holds.
Questions answered
- Why did Eyantra's profit collapse even as revenue tripled?
- The consolidated group took on the Neuro and Spine Associates healthcare business, which contributed ₹20.5 crore in hospital revenue but also generated losses, leading to a full-year consolidated net loss of ₹4.75 crore.
- What was the impact of the hospital acquisition on revenue?
- The acquisition added ₹20.5 crore in hospital services revenue to the consolidated books, helping total group revenue surge to ₹94.2 crore from around ₹31 crore a year earlier.
- Is the healthcare business already profitable?
- The consolidated group swung to a ₹6.8 crore profit in Q4, driven by a surge in hospital revenue to ₹10.4 crore. This suggests the business may be stabilising, though the full-year figures remain a net loss.
- How did the standalone business perform?
- Standalone revenue more than doubled to ₹67.5 crore, but net profit fell sharply to ₹26.5 lakh from ₹1.66 crore, indicating that the core business also faced margin pressure.
- Were there any concerns raised by the auditor?
- The statutory auditor issued an unmodified opinion on both the standalone and consolidated financial statements, meaning there were no qualifications or reservations on the numbers.
Story so far
All notes on EY →- 25 May 2026 · 7:44 PM IST Eyantra's revenue tripled after hospital deal, but full-year profit vanished
- 42d ago Eyantra's revenue tripled. Its new healthcare unit posted a ₹4.75 cr loss.